MARKETS
S&P 5007,756.2+0.57%
NASDAQ 10029,719.9+1.08%
XBI156.40+1.62%
IBB189.75+0.94%
DOW 3054,022.3+0.31%
FTSE 10010,901.0+0.17%
Biotechnology Daily

Lydall Inc. (LDL) Plunges 6.27% on January 03

Lydall Inc. (LDL) had a rough trading day for Thursday January 03 as shares tumbled 6.27%, or a loss of $-1.34 per share, to close at $20.02. After opening the day at $21.15, shares of Lydall Inc. traded as…

Editor 1 min read
Lydall Inc. (LDL) Plunges 6.27% on January 03
Lydall Inc. (LDL) Plunges 6.27% on January 03

From the Biotech Insider archive. This article dates from Jan 4, 2019 and is preserved as first published.

Lydall Inc. (LDL) had a rough trading day for Thursday January 03 as shares tumbled 6.27%, or a loss of $-1.34 per share, to close at $20.02. After opening the day at $21.15, shares of Lydall Inc. traded as high as $21.15 and as low as $19.99. Volume was 148,055 shares over 1,353 trades, against an average daily volume of 133,050 shares and a total float of 17.41 million.

As a result of the decline, Lydall Inc. now has a market cap of $348.5 million.

The stock has a P/E Ratio of 8.6.

Lydall Inc, through its subsidiaries, designs and manufactures specialty engineered filtration media, industrial thermal insulating solutions, automotive thermal and acoustical barriers, medical filtration media and devices. The company’s products are primarily sold directly to customers through an internal sales force and distributed via common carrier. Its reportable segments were Performance Materials, Technical Nonwovens, Thermal/Acoustical Metals, and Thermal/Acoustical Fibers. It derives most of its revenues from the United States of America.

The company’s products are primarily sold directly to customers through an internal sales force and distributed via common carrier.

Lydall Inc. is based out of Manchester, CT and has some 2,600 employees. Its CEO is Dale G. Barnhart.

Filed under Biotechnology Daily

More on Biotechnology Daily

See all →